" class="no-js "lang="en-US"> Dotmatics Supports Umicore Corporate R&D in Processing of Experimental Data - Medtech Alert
Saturday, February 24, 2024

Dotmatics Supports Umicore Corporate R&D in Processing of Experimental Data

Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced it has been selected by Umicore Corporate Research and Development, which is part of global materials technology and recycling company Umicore, as informatics partner for its Corporate R&D (CRD) digitalization project. The strategic agreement to implement core elements of Dotmatics’ R&D innovation platform within CRD, including electronic laboratory notebook (ELN), initially covers over 200 users and is set to run over the next 5 years.

Technology is at the core of Umicore’s success as the Company applies its unique expertise in materials science, chemistry, and metallurgy to offer solutions that enable customers to develop more sophisticated, sustainable, and safer products for cleaner mobility and other products that are essential in everyday life.

“At Umicore, we use the power of technology, innovation, and data to develop materials for a better life,” said Yves Van Rompaey, SVP Corporate Research & Development of Umicore.  “Our forward-looking approach and R&D digitalization project with the Dotmatics Platform will strengthen our world-class in-house expertise in metallurgy, chemistry and material science, allowing our Corporate R&D scientists to get the most out of all their data and further speed up innovation and process technologies.” 

Dotmatics’ platform was selected to give Umicore CRD scientists access to their data while reducing IT complexity through data standardization. Using highly configurable role-based workflows, researchers will be able to capture key scientific and operational data from design of experiments and resource planning through to executing lab activities, all with high fidelity in an Experiment Management System (EMS). The set of high-quality FAIR data (findable, accessible, interoperable, and reusable) can be analyzed to gain deep scientific insights that better inform R&D decision making. Umicore CRD scientists will have the ability to share results efficiently, avoid unnecessary rework, and streamline projects through knowledge re-use.

“We’re thrilled to have been selected by Umicore Corporate R&D for their transformational digitization project,” said Mike McKee, President of Dotmatics“The impact of the data-driven scientific research that companies like Umicore are leading cannot be understated — it will fuel the materials innovation key to making the world a healthier, cleaner, safer place to live.”

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more